Navigation Links
New Natural Product from Zurich Pharmaceuticals Downs Appetite
Date:7/24/2008

BOSTON, July 24 /PRNewswire/ -- Health and nutrition researcher Frank Ervolino, ND, investigated a product that claims success in suppressing appetite without the risks associated with stimulants. He reports that Appetite Down (http://www.appetitedown.com), a natural product from Zurich Pharmaceuticals, makes novel use of an established ingredient with promising results.

Consumers will take drastic measures to lose weight. In fact, in the U.S., where the CDC estimates that greater than 30% of adults are obese, consumers spend up to $50 billion a year to combat fat. That includes an estimated $5 billion spent in weight loss and appetite suppression supplements and 200,000 bariatric -- or weight loss -- surgeries in 2007.

Nowhere are there more promises -- and questionable results -- than in the supplement market.

A "Who's Who" of health organizations caution against weight loss and appetite suppression products. Harvard Medical School, the Mayo Clinic, and Consumer Reports all have lists of ingredients that don't work or are potentially harmful.

Even when safe, there are factors that cause concern about appetite control products. Thermogenic ingredients, like caffeine, are powerful stimulants that can be highly addictive. And non-thermogenic remedies can require daily doses of as much as 3 grams to be effective.

Ervolino has watched patients grapple with a common enemy -- the urge to eat. Appetite Down is an all-natural appetite suppression lozenge that uses Gymnema sylvestre in a proprietary formulation to curb hunger cravings. It's also caffeine-free and ephedrine-free.

Gymnema has been used as a natural remedy for blood sugar regulation for centuries. A 2003 Harvard Medical School meta-analysis reviewed over 100 clinical trials involving over 4,500 patients with diabetes or impaired glucose tolerance. It concluded that Gymnema sylvestre was safe and demonstrated "positive preliminary results."

Ervolino was impressed by another feature of Gymnema sylvestre. Research indicates that delivering gymnemic acid in a slow-dissolving lozenge can block the sense of sweetness and discourage appetite for up to 2 hours. Appetite Down does this in a slow-release lozenge that uses high-impact sweeteners to mask Gymnema's natural bitterness.

Diet management and weight loss in the U.S. are urgent and serious matters. Ervolino's research suggests that stimulant-free, non-addictive natural products like Appetite Down may provide a useful aid in the battle against obesity.

Appetite Down is a new product, and has not yet been tested in a clinical setting, but its potential is promising, Ervolino concludes.


'/>"/>
SOURCE Zurich Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vytex(TM) Natural Rubber Latex Manufacturing Test Results Get International Latex Conference Buzzing
2. Fat Grafting Provides Permanent, Natural Looking Results - Dr. Michael Law Explains Fat Injections as a New Trend in Facial Plastic Surgery
3. Sweet Dreams, Sweet Breath: MedGen Inc. Retains TransMedia Group to Send Media a Wake-Up Call About an All-Natural, Quick New Way to Slumber Land
4. The Chopra Center for Wellbeing Introduces Ayurnas: A Soothing Natural Remedy for Sinus Congestion, Chronic Headaches, and Cold Symptoms
5. Breast Augmentation Raleigh Natural Looking Results with Saline or Silicone Implants
6. Children are naturally prone to be empathic and moral
7. Stay Safe This Summer With Chemical-Free Sunscreen and DEET-Free Bug Repellent, Says Natural Solutions Magazine
8. New Injectable Collagen Filler Offers Natural Results
9. Finding suggests novel ways to boost vaccination or natural defenses
10. Natural Remedies to Treat Animals Complex Emotions
11. Figure Skater Peggy Fleming Teams With HealthSaver: Go Organic for Quality, Natural Food
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Many families have long-term insurance that covers care for a ... waiver for care if the client has a cognitive impairment diagnosis. , “What ... is often waived, so the benefits from their insurance start immediately,” said Mechell Vieira, ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... viewers the lowdown on sciatica in a new episode of "Success Files," which ... current events and innovation and investigates each subject in-depth with passion and integrity. ...
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a ... health care, have expanded their existing home health joint venture through an agreement, ... been operating a joint venture home health company with Asante, delivering clinically integrated ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:9/18/2017)... , Sept. 18, 2017 ... fields of bioinformatics and immune engineering, today ... protective avian influenza A (H7N9) vaccine. ... related to seasonal influenza and presents a ... on prior exposure to be effective. Using ...
(Date:9/12/2017)... NEW YORK , Sept. 12, 2017   EcoVadis , ... supply chains, has published the first annual edition of its Global CSR ... than 20,400 companies evaluated by EcoVadis, based on Scorecard Ratings that analyzed ... ... & Performance Index ...
(Date:9/12/2017)... , Sept. 12, 2017  ValGenesis Inc., the ... (VLMS), is pleased to announce the appointment of ... of its Board of Directors and Chairman of ... enables life science companies to manage their entire ... of paper in this process. Furthermore, ValGenesis VLMS ...
Breaking Medicine Technology: